• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy.糖尿病及早期糖尿病肾病患者对氧磷酶、芳基酯酶和同型半胱氨酸硫内酯酶活性的评估。
J Med Biochem. 2019 Mar 26;38(4):481-488. doi: 10.2478/jomb-2019-0014. eCollection 2019 Oct.
2
Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.2 型糖尿病患者血清脂蛋白相关磷脂酶 A2、对氧磷酶和同型半胱氨酸硫内酯酶活性与低密度脂蛋白中溶血磷脂酰胆碱的关系。
Diabetes Res Clin Pract. 2009 Nov;86(2):117-23. doi: 10.1016/j.diabres.2009.08.014. Epub 2009 Sep 11.
3
Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients.肾移植患者血清对氧磷酶与同型半胱氨酸硫内酯酶活性、脂肪因子及不对称二甲基精氨酸浓度之间的关系
Transplant Proc. 2013;45(10):3685-7. doi: 10.1016/j.transproceed.2013.10.003.
4
Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay.使用市售检测方法对2型糖尿病患者动脉粥样硬化与对氧磷酶或同型半胱氨酸硫内酯酶活性之间的关系进行研究。
Clin Chim Acta. 2005 Sep;359(1-2):156-62. doi: 10.1016/j.cccn.2005.03.046.
5
Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS.多囊卵巢综合征非肥胖女性的对氧磷酶乳氢酶活性(PON-HTLase)、不对称二甲基精氨酸(ADMA)和血小板激活因子乙酰水解酶(PAF-AH)活性。
Gynecol Endocrinol. 2012 Nov;28(11):874-8. doi: 10.3109/09513590.2012.683068. Epub 2012 May 24.
6
Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.2型糖尿病患者血清对氧磷酶和同型半胱氨酸硫内酯酶活性以及高密度脂蛋白抗氧化能力与心血管疾病严重程度的负相关。
Metabolism. 2006 Sep;55(9):1201-6. doi: 10.1016/j.metabol.2006.06.001.
7
The effect of age on the paraoxonase and arylesterase activity of pregnant mothers and their infants.年龄对孕妇及其婴儿的对氧磷酶和芳基酯酶活性的影响。
J Clin Lab Anal. 2012 Jul;26(4):302-6. doi: 10.1002/jcla.21521.
8
Ocular distribution of antioxidant enzyme paraoxonase & its alteration in cataractous lens & diabetic retina.抗氧化酶对氧磷酶在白内障晶状体和糖尿病视网膜中的眼内分布及其变化。
Indian J Med Res. 2017 Apr;145(4):513-520. doi: 10.4103/ijmr.IJMR_1284_14.
9
Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R.对低密度脂蛋白氧化具有保护作用所需的对氧磷酶活性位点涉及其游离巯基,且不同于其芳基酯酶/对氧磷酶活性所需的活性位点:人对氧磷酶同工酶Q和R的选择性作用。
Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1617-24. doi: 10.1161/01.atv.18.10.1617.
10
Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes.血浆同型半胱氨酸水平对2型糖尿病患者血清HTase/PON活性的影响。
Adv Ther. 2008 Sep;25(9):884-93. doi: 10.1007/s12325-008-0095-x.

引用本文的文献

1
Human Paraoxonase 1: From Bloodstream Enzyme to Disease Fighter & Therapeutic Intervention.人对氧磷酶1:从血流中的酶到疾病抵御者及治疗干预手段
Curr Protein Pept Sci. 2025;26(4):282-295. doi: 10.2174/0113892037335325241011162207.
2
The importance of paraoxonase 1 activity in chronic kidney disease.对慢性肾脏病患者血清对氧磷酶 1 活性的重视。
Ren Fail. 2024 Dec;46(2):2376930. doi: 10.1080/0886022X.2024.2376930. Epub 2024 Jul 10.
3
Paraoxonase 1 and Chronic Kidney Disease: A Meta-Analysis.对氧磷酶1与慢性肾脏病:一项荟萃分析
J Clin Med. 2023 Feb 2;12(3):1199. doi: 10.3390/jcm12031199.
4
The Hydrolysis Rate of Paraoxonase-1 Q and R Isoenzymes: An In Silico Study Based on In Vitro Data.对氧磷酶 1 Q 和 R 同工酶的水解速度:基于体外数据的计算机模拟研究。
Molecules. 2022 Oct 11;27(20):6780. doi: 10.3390/molecules27206780.
5
Saliva diagnostic utility in patients with type 2 diabetes: Future standard method.2型糖尿病患者唾液诊断的效用:未来的标准方法。
J Med Biochem. 2020 Jan 23;39(2):140-148. doi: 10.2478/jomb-2019-0019.
6
Protective Effects of an Oxovanadium(IV) Complex with NO Chelating Thiosemicarbazone on Small Intestine Injury of STZ-Diabetic Rats.NO 螯合噻唑烷酮氧钒(IV)配合物对链脲佐菌素糖尿病大鼠小肠损伤的保护作用。
Biol Trace Elem Res. 2021 Apr;199(4):1515-1523. doi: 10.1007/s12011-020-02269-7. Epub 2020 Jul 9.

本文引用的文献

1
Potential Prognostic Role of Immune System Activation Marker Neopterin in Patients with Type 2 Diabetes.免疫系统激活标志物新蝶呤在2型糖尿病患者中的潜在预后作用
J Med Biochem. 2018 Dec 1;37(4):465-469. doi: 10.2478/jomb-2018-0004. eCollection 2018 Dec.
2
Effect of Canagliflozin on Urinary Albumin Excretion in Japanese Patients with Type 2 Diabetes Mellitus and Microalbuminuria: A Pilot Study.卡格列净对伴微量白蛋白尿的日本 2 型糖尿病患者尿白蛋白排泄的影响:一项初步研究。
Diabetes Technol Ther. 2018 Oct;20(10):681-688. doi: 10.1089/dia.2018.0169. Epub 2018 Aug 10.
3
Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.对氧磷酶(PON)-1:关于遗传学、结构、多态性及临床相关性的简要概述
Vasc Health Risk Manag. 2018 Jun 18;14:137-143. doi: 10.2147/VHRM.S165173. eCollection 2018.
4
Paraoxonase activity in metabolic syndrome in children and adolescents.儿童和青少年代谢综合征中的对氧磷酶活性
Caspian J Intern Med. 2018 Spring;9(2):116-120. doi: 10.22088/cjim.9.2.116.
5
Impact of the 24-h ultramarathon race on homocysteine, oxidized low-density lipoprotein, and paraoxonase 1 levels in professional runners.24小时超级马拉松比赛对职业跑步运动员同型半胱氨酸、氧化型低密度脂蛋白和对氧磷酶1水平的影响。
PLoS One. 2018 Feb 2;13(2):e0192392. doi: 10.1371/journal.pone.0192392. eCollection 2018.
6
Oxidative Stress in Atherosclerosis.动脉粥样硬化中的氧化应激
Curr Atheroscler Rep. 2017 Sep 18;19(11):42. doi: 10.1007/s11883-017-0678-6.
7
Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies.氧化应激介导的动脉粥样硬化:机制与治疗
Front Physiol. 2017 Aug 23;8:600. doi: 10.3389/fphys.2017.00600. eCollection 2017.
8
Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy.晚期糖基化终末产物在糖尿病肾病病理过程中介导细胞和分子事件。
Biomol Concepts. 2016 Dec 1;7(5-6):293-309. doi: 10.1515/bmc-2016-0021.
9
Paraoxonase-1 activities in children and adolescents with type 1 diabetes mellitus.1型糖尿病患儿及青少年的对氧磷酶-1活性
Acta Biochim Pol. 2016;63(3):511-5. doi: 10.18388/abp.2015_1209. Epub 2016 Jun 23.
10
The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.对氧磷酶1(PON1)基因的常见变异Q192R及其活性是导致2型糖尿病患者抗氧化状态改变的部分原因。
Exp Biol Med (Maywood). 2016 Aug;241(14):1489-96. doi: 10.1177/1535370216641786. Epub 2016 Mar 27.

糖尿病及早期糖尿病肾病患者对氧磷酶、芳基酯酶和同型半胱氨酸硫内酯酶活性的评估。

Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy.

作者信息

Ayan Durmuş, Şeneş Mehmet, Çaycı Ayşe Banu, Söylemez Sibel, Eren Nezaket, Altuntaş Yüksel, Öztürk Feyza Yener

机构信息

Gazi University Faculty of Medicine, Medical Biochemistry, Ankara, Turkey.

Health Sciences University Ankara Education and Research Hospital, Medical Biochemistry, Ankara, Turkey.

出版信息

J Med Biochem. 2019 Mar 26;38(4):481-488. doi: 10.2478/jomb-2019-0014. eCollection 2019 Oct.

DOI:10.2478/jomb-2019-0014
PMID:31496913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6708292/
Abstract

BACKGROUND

The aim of this study is to examine the relationship among the changes in activities of paraoxonase (PON), arylesterase (ARE) and homocysteine thiolactonase (HTLase) enzyme having antioxidant properties and the development of diabetic nephropathy (DN), one of the most common complications of diabetes.

METHODS

Normoalbuminuric type-2 diabetic patients (Group II, n=100), microalbuminuric type 2 diabetic patients (Group III, n=100) and the control group (Group I, n=100) were included in the study. The age and gender of the patient groups matched with the age and gender of the control group. HTLase, PON and ARE enzyme activities were measured by the spectrophotometric method using a g-thiobutyrinolactone, paraoxon, and phenylacetate substrates respectively. In this study, an autoanalyzer application was developed in order to measure HTLase enzyme activity for the first time.

RESULTS

Serum HTLase, ARE and PON activities of Group III and Group II were significantly low compared to HTLase, ARE and PON results of Group I (p<0.05).

CONCLUSIONS

Based on our results, PON, ARE and HTLase enzyme activities were found to be decreased due to the increase in the degree of DN.

摘要

背景

本研究旨在探讨具有抗氧化特性的对氧磷酶(PON)、芳基酯酶(ARE)和同型半胱氨酸硫内酯酶(HTLase)的活性变化与糖尿病最常见并发症之一糖尿病肾病(DN)的发生发展之间的关系。

方法

本研究纳入了正常白蛋白尿的2型糖尿病患者(II组,n = 100)、微量白蛋白尿的2型糖尿病患者(III组,n = 100)和对照组(I组,n = 100)。患者组的年龄和性别与对照组的年龄和性别相匹配。分别使用γ-硫代丁内酯、对氧磷和苯乙酸盐底物通过分光光度法测量HTLase、PON和ARE酶的活性。在本研究中,首次开发了一种自动分析仪应用程序来测量HTLase酶的活性。

结果

与I组的HTLase、ARE和PON结果相比,III组和II组的血清HTLase、ARE和PON活性显著降低(p < 0.05)。

结论

根据我们的结果,发现由于DN程度的增加,PON、ARE和HTLase酶的活性降低。